-
In situ Hybridization Market by Technique (CISH, FISH), Application (Neuroscience, Cytology, Cancer Diagnosis, Infectious Disease), & End User (Academic And Research Institutions, Molecular Diagnostic Laboratories) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 27, 2023Select options -
Pharmaceutical Filtration Market by Technique (Microfiltration, Ultrafiltration), Application (Raw material, Final Product Processing), Product (Single-Use Systems, Membrane Filters), Scale of Operation (Manufacturing, Pilot, R&D) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 27, 2023Select options -
Cell Line Development Market by Product (Media, Equipment, Reagents), Source, Type & by Application (Tissue Engineering & Regenerative medicine, Bioproduction, Research, Toxicity Testing, Drug Discovery) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Competent Cells Market by Type (Electrocompetent, Chemically), Application (Phage Display Library Production, Subcloning, High-Throughput Cloning, Unstable DNA Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Immunoassay Market by Specimen, Application (Oncology, Infectious Diseases, Cardiology), Product & Service (Analyzers, Reagents & Kits, Software), Technology (Rapid Test, ELISA), Platform (Radioimmunoassay), End User (Hospitals) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Air Quality Monitoring System Market by Product (Fixed, Indoor, Wearable, Outdoor), Sampling (Passive, Continuous, Stack), Pollutant (VOC, Gas, Particulate Matter, Biological), End user (Petrochemical, Government, Commercial) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Protein Stability Analysis Market by End User (Research Institute, Pharmaceutical & Biotech Companies), Product (Instrument, Assay and Reagent), Technique (SPR, DSF, Spectroscopy (DLS, Fluorescence Spectroscopy), Chromatography) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Live Cell Encapsulation Market by Polymer (Silica, Alginate, Chitosan, Cellulose Sulfate), Application (Transplant, Probiotics, Research, Drug Delivery), Technique (Dripping, Coaxial Airflow, Liquid Jet) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Hollow Fiber Filtration Market by End User (CRO, Pharmaceutical Manufacturer, CMO), Technique (Ultrafiltration, Microfiltration), Material (Ceramic, Polymer), Application (Concentration, Harvest & Clarification, Perfusion) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Biomarkers Market by Product (Service, Consumables), Type (Efficacy, Safety, Validation), Disease Indication (Cardiovascular Disorders, Cancer), Application (Drug Discovery, Diagnostics Development and Development, Disease-Risk) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Bioinformatics Market by Sectors (Academics, Medical, Agriculture), Product & Service (Data Analysis Platforms, Knowledge Management Tools, Services), Applications (Proteomics, Genomics, Metabolomics) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Human Identification Market by Product & Services (Instruments, Consumables, Software), Technology (NGS, PCR, Capillary Electrophoresis, Microarray), End User (Forensic Laboratories), Application (Paternity Testing, Forensic) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Neuroscience Antibodies & Assays Market by Technology (Immunoassay, Molecular Diagnostics), Product (Reagent (Enzymes, Media, Sera, Stain, Probe), Instruments), Application, End User (Hospital, Research Institute) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Animal Genetics Market by Products & Services (Live Animals (Canine, Poultry, Porcine, Bovine), Genetic Material (Semen, Embryo), Genetic Testing (DNA Testing, DNA Typing, Genetic Disease Testing)) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 26, 2023Select options -
Gel Documentation Systems Market by End User (Academic Institutes, Biotechnology Companies), Product (Instruments, Software), Light Source (UV, Laser, LED), Detection (Chemiluminescence), Application (Nucleic Acid) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 25, 2023Select options -
Genotyping Assay Market by Technology (Sequencing, PCR, Electrophoresis, Microarray, MALDI-TOF), Application (Diagnostic Research, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics), and Product – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 25, 2023Select options -
Biopreservation Market by Product (Sera, Media, Thawing Equipment, Cryogenic Storage Systems, Alarms), Application (Regenerative Medicine, Therapeutic, Clinical Trials), Biospecimen (Stem Cells, Human Tissue, Organs), End User – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 25, 2023Select options -
Metagenomic Sequencing Market by Application (Soil Microbiome, Diagnostic), Workflow (Data Analysis, Sample Preparation), Product & Services (Consumables, Instruments, Reagents), Technology (Whole-Genome, Shotgun, 16s Rrna) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 25, 2023Select options -
Vaccines Market by Route (Oral, IM, SC, ID), Technology (Recombinant, Live, Toxoid), Disease (DTP, Rotavirus, Pneumococcal, Influenza, MMR, Varicella, Dengue, TT, Polio, Rabies, TB, shingles), Patient (Pediatric, Adult), Type – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 25, 2023Select options -
Microcarrier Market by Microcarriers (Protein coated, Cationic, Collagen), Equipment (Filtration System, Bioreactor, Culture Vessels, Cell Counter), Consumables (Serum Free Media, Sera), Application (Cell Therapy, Vaccines) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 25, 2023Select options
The Biotechnology Industry is witnessing an increase in collaborative partnerships with a view to developing newer techniques. During its “green wave” period the industry produced a number of agricultural applications. During its “red wave”, there were a number of developments in the medical space to target disease prevention and management. In its “white wave”, industrial applications were at the forefront. A further rise in demand for therapeutics and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is expected to further fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact rendering growth driver. It is expected to encourage researchers and manufacturers to increase R&D initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalised medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Our reports provide application insights, technology insights, regional insights and competitive insights on biomaterials, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology. To know more about our offerings in the Biotechnology market analysis, contact us.
The Biotechnology Industry is witnessing an increase in collaborative partnerships with the primary view of developing newer and pathbreaking technology. The market is set to expand at 9.9 percent CAGR to hit USD 775 billion by 2024 mainly on account of increase in the incidence of chronic diseases such as diabetes and cancer, development of technology innovation and favorable government conditions. The ratio of chronic disease all around the globe is continuously increasing, which is analyzed to propel growth in the industry overall. According to recent data, the estimated number of people affected by the chronic disease will rise to 629 million by 2045. Approximately half of America’s population suffers from at least one chronic disease and this number is growing continuously. These statistics are expected to pave the way for opportunities in the biotechnology market.
The industry has experienced what is known as a ‘wave’ phenomenon. During its ‘green wave’ period the industry produced a number of agricultural applications. During its ‘red wave’, there were a number of developments in the medical space to target disease prevention and management. In its ‘white wave’, industrial applications were at the forefront. A further rise in demand for therapeutic and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is also expected to boost fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact-rendering growth driver. It is expected to encourage researchers and manufacturers to increase research and development initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalized medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Global Market Studies’ Biotechnology Market Research reports analysis provide application insights, technology insights, regional insights and competitive insights vis-a-vis the subsectors of biomaterials, biomanufacturing, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology, among others. Key competitor analysis includes that of Agilent Technologies, Amgen, Abbott Laboratories, Bio-Rad Laboratories, BioGen Medical Instruments, Danaher, Merck, F. Hoffmann-La Roche, Illumina, PerkinElmer, Thermo Fisher Scientific and Qiagen.
Contact us at Global Market Studies to know more about our offerings in the Biotechnology sector.